Post-approval studies (Phase 4)Study completedNCT01426802
What this trial is testing
Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Who this might be right for
Type 2 Diabetes Mellitus
Novartis Pharmaceuticals 150